Inventor · disambiguated record
Lawrence B. Snyder
Also filed as: SNYDER LAWRENCE · SNYDER LAWRENCE B
49 granted patents·20 pending applications·666 citations·filing 1994–2025
98Inventor score
Files withARVINAS OPERATIONS INC32BRISTOL MYERS SQUIBB CO20BACHAND CAROL6ARVINAS INC5SLOAN KETTERING INST CANCER2
Top patents by PatentIndex Score
69 records- 0198US11883393B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2020·Granted Jan 30, 2024·5 cites·4 claims
- 0298US11236051B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2020·Granted Feb 1, 2022·9 cites·3 claims
- 0398US10844021B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2019·Granted Nov 24, 2020·13 cites·25 claims
- 0498US10584101B2Compounds and methods for the targeted degradation of androgen receptorARVINAS INC·Filed 2017·Granted Mar 10, 2020·35 cites·6 claims
- 0598US7741347B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 22, 2010·52 cites·13 claims
- 0697US11952347B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2021·Granted Apr 9, 2024·3 cites·7 claims
- 0797US10730870B2Compounds and methods for the enhanced degradation of targeted proteinsARVINAS INC·Filed 2016·Granted Aug 4, 2020·25 cites·22 claims
- 0897US8303944B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2008·Granted Nov 6, 2012·36 cites·13 claims
- 0997US7704992B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Apr 27, 2010·58 cites·25 claims
- 1097US7659270B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Feb 9, 2010·72 cites·25 claims
- 1196US7906655B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Mar 15, 2011·37 cites·28 claims
- 1296US7759495B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jul 20, 2010·41 cites·31 claims
- 1396US7745636B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 29, 2010·53 cites·26 claims
- 1495US12077509B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2023·Granted Sep 3, 2024·1 cites·4 claims
- 1595US8574563B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2012·Granted Nov 5, 2013·18 cites·26 claims
- 1692US11964945B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2020·Granted Apr 23, 2024·2 cites·26 claims
- 1792US8846023B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Sep 30, 2014·7 cites·13 claims
- 1892US8642025B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Feb 4, 2014·12 cites·40 claims
- 1991US8147818B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2009·Granted Apr 3, 2012·22 cites·22 claims
- 2091US5525731ACamptothecin analogues and methods of preparation thereofSLOAN KETTERING INST CANCER·Filed 1994·Granted Jun 11, 1996·35 cites·36 claims
- 2189US11191741B2Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptideARVINAS OPERATIONS INC·Filed 2017·Granted Dec 7, 2021·3 cites·13 claims
- 2289US8492553B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2012·Granted Jul 23, 2013·11 cites·31 claims
- 2389US7183302B2Iminothiazolidinones as inhibitors of HCV replicationBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Feb 27, 2007·32 cites·19 claims
- 2489US2025034096A1Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 2588US9227961B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 5, 2016·6 cites·12 claims
- 2687US8288562B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2010·Granted Oct 16, 2012·9 cites·31 claims
- 2786US6465456B2Isoxazolinone antibacterial agentsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Oct 15, 2002·19 cites·22 claims
- 2885US12427144B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2023·Granted Sep 30, 2025·0 cites·16 claims
- 2985US11427548B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2019·Granted Aug 30, 2022·2 cites·15 claims
- 3083US9018390B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 28, 2015·4 cites·31 claims
- 3183US8735398B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted May 27, 2014·6 cites·15 claims
- 3282US8383094B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Feb 26, 2013·3 cites·18 claims
- 3382US8093243B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2009·Granted Jan 10, 2012·5 cites·26 claims
- 3482US2025223265A1Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 3579US12441708B2Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2022·Granted Oct 14, 2025·0 cites·20 claims
- 3679US12239711B2Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2022·Granted Mar 4, 2025·0 cites·1 claims
- 3779US8143288B2Inhibitors of HCV replicationSERRANO-WU MICHAEL·Filed 2006·Granted Mar 27, 2012·5 cites·21 claims
- 3878US12264157B2Compounds and methods for the enhanced degradation of targeted proteinsARVINAS OPERATIONS INC·Filed 2022·Granted Apr 1, 2025·0 cites·24 claims
- 3978US2025313547A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2025·Application pending·0 cites
- 4077US8362020B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Jan 29, 2013·3 cites·18 claims
- 4177US2025360219A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2025·Application pending·0 cites
- 4275US8796466B2Hepatitis C virus inhibitorsBENDER JOHN A·Filed 2010·Granted Aug 5, 2014·3 cites·4 claims
- 4374US2025236612A1Rapidly accelerating fibrosarcoma protein degrading compounds and associated methods of useARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 4474US2021040044A1Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2020·Application pending·0 cites
- 4572US2024325547A1Modulators of bcl6 proteolysis and associated methods of useARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 4671US8691821B2Oxazolidinones as modulators of mGluR5DEGNAN ANDREW P·Filed 2011·Granted Apr 8, 2014·3 cites·14 claims
- 4768US12419960B2Compounds and methods for the targeted degradation of androgen receptor and associated methods of useARVINAS OPERATIONS INC·Filed 2021·Granted Sep 23, 2025·0 cites·20 claims
- 4868USRE49735EOxazolidinones as modulators of MGLUR5BRISTOL MYERS SQUIBB CO·Filed 2021·Granted Nov 28, 2023·0 cites·16 claims
- 4968US6420349B1Isoxazolinone antibacterial agentsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jul 16, 2002·4 cites·7 claims
- 5068US2020155690A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lawrence B. Snyder files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →